
22 Jul Holostem
Matteo Piazza, Ph.D., Business Development and Commercial Director
Oct. 7 | 10:15am | FLW Ballroom F
Modena, Italy
(Private)
Holostem s.r.l., founded in 2008, is Italy’s first biotechnology company dedicated to the development, manufacture, registration, and commercial distribution of Advanced Therapy Medicinal Products (ATMPs) based on epithelial stem cell cultures for both cell and gene therapy. These therapies target personalized medicine for patients with severe epithelial orphan diseases that have significant unmet needs.